Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis

BACKGROUND: Having been approved for biological treatment of atopic dermatitis, dupilumab has also been recently licensed as add-on therapy for severe asthma and nasal polyposis. With regard to the latter diseases, few real-life clinical investigations have been carried out to date. OBJECTIVE: The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelaia, Corrado, Lombardo, Nicola, Busceti, Maria Teresa, Piazzetta, Giovanna, Crimi, Claudia, Calabrese, Cecilia, Vatrella, Alessandro, Pelaia, Girolamo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478424/
https://www.ncbi.nlm.nih.gov/pubmed/34594115
http://dx.doi.org/10.2147/JAA.S328988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478424/
https://www.ncbi.nlm.nih.gov/pubmed/34594115
http://dx.doi.org/10.2147/JAA.S328988

Ejemplares similares